BioXcel takes surprising path with IPO of oncology spinout OnkosXcel

BioXcel takes surprising path with IPO of oncology spinout OnkosXcel

Source: 
Fierce Biotech
snippet: 

In a move that analysts called surprising, BioXcel Therapeutics is moving immuno-oncology subsidiary OnkosXcel towards an IPO.